Trials / Conditions / Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

31 registered clinical trials studyying Primary Open Angle Glaucoma (POAG) — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glau NCT07119905	Sohag University	—
Not Yet Recruiting	Personalized Mobile Reminders for Medication Adherence and Intraocular Pressure Control in Primary Open-Angle NCT07480577	Sakarya Yenikent State Hospital	N/A
Not Yet Recruiting	Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries NCT07418853	Henry Ford Health System	N/A
Recruiting	Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract NCT07462000	Military Institute od Medicine National Research Institute	N/A
Recruiting	Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension NCT07335211	Huons Co., Ltd.	Phase 3
Recruiting	GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma NCT06921317	IVIEW Therapeutics Inc.	Phase 1 / Phase 2
Recruiting	UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma NCT07454447	Minia University Hospital	—
Recruiting	Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open An NCT07147647	Select Eye Care	N/A
Recruiting	Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma NCT07322965	Institut Catala de Retina	N/A
Recruiting	A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma NCT06792422	Glostrup University Hospital, Copenhagen	Phase 4
Recruiting	A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glauco NCT06615661	Iantrek, Inc.	—
Completed	Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients NCT06016972	Qlaris Bio, Inc.	Phase 2
Completed	Effect of Niacinamide Supplementation in Glaucoma NCT07007260	University of Medicine and Pharmacy Craiova	N/A
Completed	MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) NCT06437639	Pharmasoft	Phase 4
Not Yet Recruiting	Role of Peripheral Vision in Scene Perception (PERISCE) NCT05539508	University Hospital, Grenoble	—
Completed	Trabecular Microbypass IStent in Patients with Glaucoma NCT06630546	Yu-Ting Tsao	N/A
Completed	Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG) NCT06903156	Pharmasoft	Phase 2
Terminated	iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications NCT03478293	Glaukos Corporation	N/A
Completed	Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma NCT03131167	Shire	Phase 1
Completed	Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG NCT02829996	Inotek Pharmaceuticals Corporation	Phase 2
Completed	A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial NCT02700984	Alcon Research	N/A
Completed	Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma NCT02565173	Inotek Pharmaceuticals Corporation	Phase 3
Completed	Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma NCT02434692	Implandata Ophthalmic Products GmbH	N/A
Terminated	Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension NCT02226094	OcuTherix, Inc.	Phase 1 / Phase 2
Completed	A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension NCT01917383	Inotek Pharmaceuticals Corporation	Phase 2
Completed	One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects NCT01517477	Glaukos Corporation	N/A
Terminated	Safety Study of Latanoprost Slow Release Insert NCT01180062	Daniel Moore	Phase 1
Completed	Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction o NCT01252849	Glaukos Corporation	N/A
Unknown	Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Ad NCT00902109	University Hospital Tuebingen	—
Completed	Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical NCT01166659	Transcend Medical, Inc.	N/A
Completed	Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surg NCT01085357	Transcend Medical, Inc.	N/A